Separate names with a comma.
Atai Life Sciences CEO provides updates and outlines next steps for BPL-003 and other program [MEDIA]
GH Research (GH001, inhalable 5‑MeO‑DMT): Reported strong Phase 2b data in February 2025, showing a placebo‑adjusted MADRS reduction of ~15.5...
#AlphaNooner - Inside $ATAI with Christian Angermayer [MEDIA]
Mind Medicine: Heading In The Right Direction https://seekingalpha.com/article/4803842-mind-medicine-heading-in-the-right-direction
ATAI Chairman Predicts his Company will Capture most of a Market Generating over 40b in Revenue a Year....
[IMG] 1. Expanding, differentiated product suite Sekur offers fully Swiss-hosted privacy tech—including encrypted email (SekurMail) with...
[IMG]
ATAI will squeeze soon
PBS - RFK Jr. suggests psychedelic therapy for depression and trauma has Trump administration’s support...
Atai Therapeutics discovers new 5-HT2A receptor partial agonists July 16, 2025 Atai Therapeutics Inc. has synthesized new tetrahydro...
List of Patent Activity on 2025 for MindMed US20250205196 – Formulations of Psilocin with Enhanced Stability Jurisdiction: United States...
This company will possibly acquire $ATAI, $MNMD and or $CMPS very very soon.
$ATAI$JNJ reported Q2 2025 sales of $414 million for SPRAVATO (esketamine), marking a 53% year-over-year increase—this momentum is driven by...
$ATAI J&J doesn't have to 'do deals out of desperation' despite facing patent cliffs: CFO...
$MNMD J&J doesn't have to 'do deals out of desperation' despite facing patent cliffs: CFO...
RFK Jr. and other Trump officials embrace psychedelics after FDA setback...
Sekur Private Data Ltd. (OTCQB: SWISF | CSE: SKUR) [MEDIA] Sekur (SWISF | SKUR) is a privacy-first communication platform based in Switzerland...
